Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuqin Dai

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Plos One|March 8, 2013
Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patientsYanan Kong, Junye Wang, Wanli Liu, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 2, 2022
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign NodulesYanzhen Lai, Yu Wang, Yaxian Wu, et al.
Clinical and Translational Medicine|February 6, 2025
RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic-nuclear shuttling in human triple-negative breast cancerShumei Huang, Dongni Shi, Shuqin Dai, et al.
Cancer Research|September 16, 2022
MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular CarcinomaYunyun Xiao, Yue Li, Dongni Shi, et al.
The Oncologist|December 5, 2025
Estradiol levels in women with hormone receptor-positive advanced breast cancer on fulvestrant therapyShuqin Dai, Yanling Wen, Xingping Wu, et al.
Breast (Edinburgh, Scotland)|October 2, 2024
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancerShuqin Dai, Xingping Wu, Xuefang Huang, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Plos One|March 8, 2013
Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patientsYanan Kong, Junye Wang, Wanli Liu, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 2, 2022
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign NodulesYanzhen Lai, Yu Wang, Yaxian Wu, et al.
Clinical and Translational Medicine|February 6, 2025
RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic-nuclear shuttling in human triple-negative breast cancerShumei Huang, Dongni Shi, Shuqin Dai, et al.
Cancer Research|September 16, 2022
MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular CarcinomaYunyun Xiao, Yue Li, Dongni Shi, et al.
The Oncologist|December 5, 2025
Estradiol levels in women with hormone receptor-positive advanced breast cancer on fulvestrant therapyShuqin Dai, Yanling Wen, Xingping Wu, et al.
Breast (Edinburgh, Scotland)|October 2, 2024
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancerShuqin Dai, Xingping Wu, Xuefang Huang, et al.
Pageof 4